Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions

Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions

With the progression of tumor treatment, the 5-year survival rate of breast cancer is close to 90%. Cardiovascular toxicity caused by chemotherapy has become a vital factor affecting the survival of patients with breast cancer. Anthracyclines, such as doxorubicin, are still some of the most effectiv...

Full description

Bibliographic Details
Main Authors: Chunping Liu, Huiqi Chen, Sien Guo, Qiaojing Liu, Zhijun Chen, Haiding Huang, Qi Zhao, Longmei Li, Huan Cen, Zebo Jiang, Qiyuan Luo, Xiaoling Chen, Jiaxiong Zhao, Wensheng Chen, Phillip C. Yang, Lei Wang
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Cardiomyopathy
Cardiotoxicity
Chemotherapy
Breast cancer
Anthracycline
Trastuzumab
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223011691

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223011691

Similar Items